News

Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, announced that the FDA has approved IMKELDI (imatinib) oral solution, the first oral liquid form of imatinib…
Read More...

GSK plc announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved a regulatory application to extend the indication of Arexvy (respiratory syncytial virus…
Read More...

Kura Oncology, Inc. and Kyowa Kirin Co., Ltd. announced they have entered into a global strategic collaboration to develop and commercialize ziftomenib, Kura's selective oral menin…
Read More...

Zai Lab and Pfizer announced a strategic collaboration for the novel antibacterial drug XACDURO (sulbactam-durlobactam) in mainland China. Pfizer’s affiliated companies will be…
Read More...

Amneal Pharmaceuticals, Inc. announced the advancement of two key strategic initiatives. First, the Company has resubmitted to the U.S. Food and Drug Administration (FDA) its new drug…
Read More...

Enveda, a biotechnology company using AI to translate nature into new medicines, announced an oversubscribed $130 million Series C funding round led by Kinnevik and FPV with…
Read More...

Samsung Biologics announced a series of manufacturing deals with a Europe-based pharmaceutical company. The disclosed deals, worth over USD 668 million combined, will run through…
Read More...

Genprex, Inc., a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, announced it has entered into an exclusive…
Read More...

Pfizer Inc. announced that the European Commission (EC) has granted marketing authorization for HYMPAVZI (marstacimab) for the routine prophylaxis of bleeding episodes in patients 12…
Read More...

Alloy Therapeutics Inc., a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug discovery technologies, announced a strategic collaboration and license…
Read More...

AstraZeneca and Daiichi Sankyo have submitted a new Biologics License Application (BLA) for accelerated approval in the US for datopotamab deruxtecan (Dato-DXd) for the treatment of…
Read More...

Nippon Shinyaku Co., Ltd. and Atsena Therapeutics, Inc. have entered into an exclusive license agreement for the commercialization of ATSN-101 in the territory of the U.S. and for the…
Read More...

BioNTech SE  and Biotheus announced the signing of a definitive agreement for the acquisition of Biotheus, a clinical-stage biotechnology company dedicated to the discovery and…
Read More...

QIAGEN announced a collaboration with the McGill University Centre for Microbiome Research to support microbiome research activities and outcomes. The three-year partnership will…
Read More...

Apollo Therapeutics Group Limited (“Apollo”), the portfolio biopharmaceutical company, and Sunshine Lake Pharma Co., Ltd. (“Sunshine Lake”), an innovative pharmaceutical company and a…
Read More...

Ontada®, a McKesson business and leader in community oncology real-world data, clinical education, and point of care technologies, has announced a strategic collaboration with Datavant,…
Read More...

GSK announced that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or disease-related symptoms, in adult patients with intermediate or high-risk…
Read More...

Novavax, Inc., a global company advancing protein-based vaccines with its Matrix-M adjuvant, announced that the U.S. Food and Drug Administration (FDA) has removed the clinical hold on…
Read More...

Aditum Bio and Leads Biolabs announced the formation of Oblenio Bio, which is being formed in conjunction with an exclusive option and license agreement to develop LBL-051, a…
Read More...

Clearside Biomedical, Inc., a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS), announced that the…
Read More...